Biologics Safety Testing Market: A Growing Demand for Rigorous Quality Control
Increasing development and commercialization of new biotherapeutics are driving remarkable growth in the biologics safety testing market. The increased complexity of therapies has created a demand for rigorous safety testing for efficacy with minimal side effects. This blog will consider key factors driving market growth, emerging trends, and the future outlook of this critical industry. Market Dynamics Several factors contribute to the growth of the biologics safety testing market, including: • Growing Prevalence of Chronic Diseases: The increasing prevalence of chronic diseases, including cancer, autoimmune disorders, and infectious diseases, demands new innovative biologics. • Advances in Biotechnology: The rapid advances in biotechnology have enabled complex biologics such as monoclonal antibodies, recombinant proteins, and cell and gene therapies to be developed. • Stringent Regulatory Requirements: Regulatory bodies worldwide are imposin...